PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)
Author:
Funder
Science and Engineering Research Board
Publisher
Elsevier BV
Subject
Cell Biology
Reference56 articles.
1. Challenges of the oral cancer burden in India;Coelho;J. Cancer Epidemiol.,2012
2. Survival from head and neck cancer in Mumbai (Bombay), India;Yeole;Cancer.,2000
3. Mechanisms of angiogenesis and arteriogenesis;Carmeliet;Nat. Med.,2000
4. Molecular regulation of angiogenesis and lymphangiogenesis;Adams;Nat. Rev. Mol. Cell Biol.,2007
5. The great escape; the hallmarks of resistance to antiangiogenic therapy;van Beijnum;Pharmacol. Rev.,2015
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer;Frontiers in Oncology;2024-08-02
2. Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment;Cancer Treatment Reviews;2024-06
3. Therapeutic prospects of nectin-4 in cancer: applications and value;Frontiers in Oncology;2024-03-28
4. Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation;Medical Oncology;2024-01-06
5. Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy;Translational Oncology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3